chr7-103376701-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_198999.3(SLC26A5):c.2041+107T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00522 in 889,448 control chromosomes in the GnomAD database, including 150 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 102 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 48 hom. )
Consequence
SLC26A5
NM_198999.3 intron
NM_198999.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0160
Publications
1 publications found
Genes affected
SLC26A5 (HGNC:9359): (solute carrier family 26 member 5) This gene encodes a member of the SLC26A/SulP transporter family. The protein functions as a molecular motor in motile outer hair cells (OHCs) of the cochlea, inducing changes in cell length that act to amplify sound levels. The transmembrane protein is an incomplete anion transporter, and does not allow anions to cross the cell membrane but instead undergoes a conformational change in response to changes in intracellular Cl- levels that results in a change in cell length. The protein functions at microsecond rates, which is several orders of magnitude faster than conventional molecular motor proteins. Mutations in this gene are potential candidates for causing neurosensory deafness. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]
SLC26A5 Gene-Disease associations (from GenCC):
- autosomal recessive nonsyndromic hearing loss 61Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 7-103376701-A-G is Benign according to our data. Variant chr7-103376701-A-G is described in ClinVar as Benign. ClinVar VariationId is 1269285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0694 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC26A5 | ENST00000306312.8 | c.2041+107T>C | intron_variant | Intron 19 of 19 | 1 | NM_198999.3 | ENSP00000304783.3 | |||
| SLC26A5 | ENST00000393727.5 | c.2047+107T>C | intron_variant | Intron 17 of 17 | 1 | ENSP00000377328.1 | ||||
| SLC26A5 | ENST00000393723.2 | c.1951+107T>C | intron_variant | Intron 16 of 16 | 1 | ENSP00000377324.1 |
Frequencies
GnomAD3 genomes AF: 0.0205 AC: 3114AN: 152142Hom.: 103 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3114
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00207 AC: 1525AN: 737188Hom.: 48 AF XY: 0.00171 AC XY: 666AN XY: 388956 show subpopulations
GnomAD4 exome
AF:
AC:
1525
AN:
737188
Hom.:
AF XY:
AC XY:
666
AN XY:
388956
show subpopulations
African (AFR)
AF:
AC:
1224
AN:
16732
American (AMR)
AF:
AC:
102
AN:
27788
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19026
East Asian (EAS)
AF:
AC:
0
AN:
31742
South Asian (SAS)
AF:
AC:
8
AN:
57438
European-Finnish (FIN)
AF:
AC:
0
AN:
45968
Middle Eastern (MID)
AF:
AC:
10
AN:
3018
European-Non Finnish (NFE)
AF:
AC:
19
AN:
500644
Other (OTH)
AF:
AC:
162
AN:
34832
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
61
122
182
243
304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0205 AC: 3120AN: 152260Hom.: 102 Cov.: 32 AF XY: 0.0200 AC XY: 1491AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
3120
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
1491
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
2972
AN:
41526
American (AMR)
AF:
AC:
107
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68012
Other (OTH)
AF:
AC:
35
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
147
294
441
588
735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3458
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.